Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 43.9% ($ weighted). The appreciation of Anthropic was the main contributor to the mark up, as it’s widely held across funds. There was an average mark-up of 17.7% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In July, 21% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 45% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: May 31st, 2026 Reporting Period

43.9%

Appreciation/Depreciation of All Reported Holdings1

17.7%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Xsight Labs
285.2%
Empower Semi
265.8%
Candid
206.6%
Element Labs
165.8%
Anthropic
127.3%
Physical Intelligence
70.8%
Thriveworks
61.0%
Asapp
47.3%
Genesis Therapeutics
39.9%
GupShup
30.1%
Bytedance
29.4%
City Therapeutics
25.7%
Neurona Therapeutics
24.7%
LifeMine
23.7%
Tipalti
23.2%
Astranis
22.9%
Crusoe Energy
20.9%
Moloco
18.8%
Aledade
18.6%
Socure
18.1%
PsiQuantum
17.8%
Tenstorrent
17.1%
Algolia
16.7%
Retym
15.5%
Triveni Bio
15.4%
Alif Semi
14.6%
Akeana
13.9%
Lightmatter
12.3%
SiMa ai
11.8%
CelLink
11.2%
SambaNova
10.1%
Diamond Foundry
9.2%
Cellanome
8.6%
Anduril
8.5%
Caidya (dMed)
8.3%
Blink Health
8.1%
Fanatics
7.9%
goPuff
6.7%
Rapyd
6.2%
Fabletics
6.1%
A24 Films
4.2%
Galvanize
4.2%
JUUL
4.0%
Cardurion
3.8%
Bolt
3.5%
Farmers Business Network
3.5%
OpenAI
3.3%
Databricks
2.7%
Kartos Therapeutics
2.4%
Waymo
2.4%
MasterClass
1.9%
Mirador Therapeutics
0.5%
Snyk
0.5%
Treeline Bio
0.4%
Altos Labs
0.0%
Arctic Wolf
0.0%
Bright Peak
0.0%
Druva
0.0%
EndeavorBio
0.0%
Epirus
0.0%
FLEXE
0.0%
GOAT
0.0%
Gusto
0.0%
HaulHub
0.0%
Kardigan
0.0%
KoBold Metals
0.0%
Long Wall (ABL Space)
0.0%
Menlo Micro
0.0%
Nuro
0.0%
PrognomIQ
0.0%
Quell
0.0%
Rappi
0.0%
RefleXion Medical
0.0%
Runway AI
0.0%
Savage X
0.0%
Sila Nano
0.0%
Stripe
0.0%
Superhuman (Grammarly)
0.0%
VAST Data
0.0%
VideoAmp
0.0%
Zipline
0.0%
Castle Creek
-0.2%
Cellares
-0.2%
Revolut
-0.2%
World Labs
-0.2%
Unqork
-0.3%
Ankyra
-0.5%
Frore Systems
-0.5%
Wugen
-0.5%
Deep Genomics
-0.7%
Evozyne
-1.0%
Checkr
-1.2%
T-Knife
-1.4%
Bombas
-1.5%
Element Bio
-1.8%
Starling Bank
-3.3%
Cleerly
-3.7%
Asimov
-4.1%
Skyhawk
-4.3%
Redwood Materials
-4.4%
Sonoma Bio
-4.5%
Kardium
-4.8%
Canva
-4.9%
Goop
-5.1%
Oura Health
-5.3%
Applied Intuition
-5.5%
Ant Group
-6.2%
Dataminr
-6.7%
Insightec
-8.0%
Medical Micro
-8.5%
Discord
-9.2%
ElevateBio
-9.4%
Freenome
-9.4%
Skyryse
-11.2%
Resilience
-12.3%
Tory Burch
-14.1%
Epic Games
-19.5%
Insitro
-20.0%
SecurityScorecard
-31.7%
DataRobot
-31.9%
Tarana
-38.0%
Honor Tech
-54.5%
Signifyd
-61.0%
Verily
-66.3%
Enevate
-100.0%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 43.9% ($ weighted). The appreciation of Anthropic was the main contributor to the mark up, as it’s widely held across funds. There was an average mark-up of 17.7% (equal weighted).

Xsight Labs experienced the most significant mark-up, followed by Empower Semi, Candid and Element Labs. Semiconductors, AI & Machine Learning and Marketing Tech saw the largest mark-ups across sectors.

Enevate experienced the most significant mark-down, as funds wrote off their positions. Verily and Signifyd also saw significant mark-downs. Among sectors, SaaS, Cybersecurity and FinTech saw the most significant mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Applied Intuition1+87.00%
Checkr1+59.00%
Dataminr2+40.40%
Algolia1+38.00%
Anduril7+34.70%
Discord2+30.10%
Canva2+28.10%
Anthropic8+27.80%
Crusoe Energy4+24.60%
Revolut2+17.00%
Databricks4+14.40%
Tenstorrent2+10.60%
Stripe7+6.00%
Bytedance1+3.10%
Gusto1+1.90%
OpenAI6+0.10%
Epic Games1-1.20%
Bolt1-4.60%
VAST Data2-7.10%
SambaNova1-11.00%
Lightmatter3-11.70%
Redwood Materials1-15.30%
Zipline2-17.40%
Superhuman (Grammarly)1-19.00%
KoBold Metals2-20.10%
PsiQuantum2-24.50%
Oura Health1-28.00%
Arctic Wolf1-34.30%
Fanatics1-42.10%
Snyk1-48.00%
Druva1-57.30%
Astranis1-64.00%
Groq2-87.50%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In July, 21% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 45% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Applied Intuition, Checkr and Dataminr had the highest positive variance in reported marks versus ZX Index Values. Groq, Astranis and Druva had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Resilience.63$4.60$21.87$3.39
Farmers Business Network.40$0.86$1.08$0.00
Honor Tech.39$0.62$0.80$0.30
Superhuman (Grammarly).33$16.06$25.60$13.10
MasterClass.26$1.94$2.41$1.42

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period Resilience ($3.39 - $21.87) saw the highest share price variance across funds followed by Farmers Business Network ($0.00 - $1.08) and Honor Tech ($0.30 - $0.80).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
MasterClass
19
Asapp
4
Tipalti
4
Akeana, Aledade, Bolt
2
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Kardium
5
Cleerly
4
Revolut
4
Tarana
4

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

MasterClass saw its first positive reversal in nineteen quarters while Asapp and Tipalti saw their first positive reversals in four quarters. Kardium saw its first negative reversal in five quarters while Cleerly, Revolut and Tarana all saw their first negative reversals in four quarters.

Disclaimer

This report is based on data reported by 300+ funds and $110+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report July not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right